Josef Marksteiner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Josef Marksteiner has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Christian Humpel
Department of General and Social Psychiatry, Innsbruck Medical University, Austria
3 shared publications- Elisabeth Margarete Weiss
Department of Psychology, University of Innsbruck, 6020 Innsbruck, Austria
3 shared publications Hartmann Hinterhuber
3 shared publicationsKurt Jellinger
3 shared publicationsChristina Wehringer
2 shared publicationsElisabeth Stögmann
2 shared publications
Latest Publications
- 26 July 2010
- Published by Dustri-Verlag Dr. Karl Feistle in neuropsychiatrie
Zusammenhang zwischen Mild Cognitive Impairment (MCI) und Depression
- 26 July 2010
- Published by Dustri-Verlag Dr. Karl Feistle in neuropsychiatrie
Zusammenhang zwischen Mild Cognitive Impairment (MCI) und Depression
- 1 January 2010
- Vol. 24 (2) , 88-98
[Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors].
The first part of this article deals with the concept of Mild Cognitive Impairment and its role in the pathogenesis of dementia. In the second part neuroradiologic diagnostic methods which can potentially help to predict the conversion of MCI to Alzheimer s disease (DAT) are discussed. We reviewed in PubMed published literature for reports which investigated diagnosis and progress of patients with MCI and DAT. Patients with MCI older than 65 years have a risk of 10-15%/year to develop dementia in comparison to the healthy population with a risk of 2%/year. Neuroradiologic methods such as MR-spectroscopy, FDGPET, DWI and VBM are able to differentiate patients who will convert to DAT from patients who remain stable. Structural changes can be detected prior to clinically measurable cognitive deficits. The neuroradiologic examination using MR- Spectroscopy, VBM, DWI or FDG-PET show early structural and functional changes which can predict a conversion from MCI to DAT.
- 1 January 2010
- Vol. 24 (2) , 88-98
[Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors].
The first part of this article deals with the concept of Mild Cognitive Impairment and its role in the pathogenesis of dementia. In the second part neuroradiologic diagnostic methods which can potentially help to predict the conversion of MCI to Alzheimer s disease (DAT) are discussed. We reviewed in PubMed published literature for reports which investigated diagnosis and progress of patients with MCI and DAT. Patients with MCI older than 65 years have a risk of 10-15%/year to develop dementia in comparison to the healthy population with a risk of 2%/year. Neuroradiologic methods such as MR-spectroscopy, FDGPET, DWI and VBM are able to differentiate patients who will convert to DAT from patients who remain stable. Structural changes can be detected prior to clinically measurable cognitive deficits. The neuroradiologic examination using MR- Spectroscopy, VBM, DWI or FDG-PET show early structural and functional changes which can predict a conversion from MCI to DAT.
- 1 January 2010
- Published by Elsevier in Experimental Gerontology
- Vol. 45 (1) , 70-74
Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment
- 1 January 2010
- Published by Elsevier in Experimental Gerontology
- Vol. 45 (1) , 70-74
Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment
- 31 July 2009
- Published by Elsevier in Experimental Gerontology
- Vol. 44 (6-7) , 370-371
Glycogen-synthase kinase-3β is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairment
- 31 July 2009
- Published by Elsevier in Experimental Gerontology
- Vol. 44 (6-7) , 370-371
Glycogen-synthase kinase-3β is decreased in peripheral blood mononuclear cells of patients with mild cognitive impairment
- 1 January 2009
- Vol. 23 (1) , 4-14
[Dementia and music].
Patients suffering from dementia are nevertheless still able to render exceptional musical performances. For example, they can recognize music from childhood and reproduce lyrics and melodies of songs with four verses. Furthermore, behavioural symptoms such as psycho- motor agitation and crying, but also aggressive behaviour can be positively influenced by music and motivation and positive emotions can be increased. A variety of physiological and psychological changes occur when patients are listening to music. Previous research could show that music activated different parts of the brain especially in the temporal cortex, but also motoric areas in the frontal cortex, thalamus and cerebellum were essential for rhythm, melody and harmony perception and processing. Music therapy is an interpersonal process in which music is used within a therapeutic relationship to address physical, emotional, cognitive, and social needs of individuals with various psychiatric or medical conditions. However, until now only little research has been directed towards non-pharmacological treatments like music therapy in dementia patients. Further research is warranted to investigate the long term influence of music therapy on patients suffering from dementia.
- 1 January 2009
- Vol. 23 (1) , 4-14
[Dementia and music].
Patients suffering from dementia are nevertheless still able to render exceptional musical performances. For example, they can recognize music from childhood and reproduce lyrics and melodies of songs with four verses. Furthermore, behavioural symptoms such as psycho- motor agitation and crying, but also aggressive behaviour can be positively influenced by music and motivation and positive emotions can be increased. A variety of physiological and psychological changes occur when patients are listening to music. Previous research could show that music activated different parts of the brain especially in the temporal cortex, but also motoric areas in the frontal cortex, thalamus and cerebellum were essential for rhythm, melody and harmony perception and processing. Music therapy is an interpersonal process in which music is used within a therapeutic relationship to address physical, emotional, cognitive, and social needs of individuals with various psychiatric or medical conditions. However, until now only little research has been directed towards non-pharmacological treatments like music therapy in dementia patients. Further research is warranted to investigate the long term influence of music therapy on patients suffering from dementia.
- 1 January 2009
- Vol. 23 (3) , 144-50
[Association of Mild Cognitive Impairment (MCI) and depression].
Mild Cognitive Impairment is a heterogeneous entity. Incidence and prevalence of MCI are highly dependent on the diagnostic criteria applied. Geriatric depression is more frequently associated with cognitive deficits and somatic complaints than depression in younger age. Consequently, depressive symptoms in the elderly are often misinterpreted and not treated adequately. The aim of this review is to point out possible explanations for the high incidence of depression in patients with MCI and to compare prior studies who worked on this interrelation. We review the existing literature on the relationship between MCI and depression. There is no consensus on the question whether depression is the consequence or the cause for cognitive impairment in older people. The comparability of prior studies which dealt with the relationship between depression and MCI is limited due to the use of different diagnostic criteria and depression scales. It can be concluded that there is an association between MCI and depression which leads to a worse clinical outcome of depression and maybe a faster progression of cognitive decline.
- 1 January 2009
- Vol. 23 (3) , 144-50
[Association of Mild Cognitive Impairment (MCI) and depression].
Mild Cognitive Impairment is a heterogeneous entity. Incidence and prevalence of MCI are highly dependent on the diagnostic criteria applied. Geriatric depression is more frequently associated with cognitive deficits and somatic complaints than depression in younger age. Consequently, depressive symptoms in the elderly are often misinterpreted and not treated adequately. The aim of this review is to point out possible explanations for the high incidence of depression in patients with MCI and to compare prior studies who worked on this interrelation. We review the existing literature on the relationship between MCI and depression. There is no consensus on the question whether depression is the consequence or the cause for cognitive impairment in older people. The comparability of prior studies which dealt with the relationship between depression and MCI is limited due to the use of different diagnostic criteria and depression scales. It can be concluded that there is an association between MCI and depression which leads to a worse clinical outcome of depression and maybe a faster progression of cognitive decline.
- 26 August 2008
- Published by Dustri-Verlag Dr. Karl Feistle in neuropsychiatrie
Geschlechtsspezifische Unterschiede der Alzheimer Demenz
- 26 August 2008
- Published by Dustri-Verlag Dr. Karl Feistle in neuropsychiatrie
Geschlechtsspezifische Unterschiede der Alzheimer Demenz
- 18 March 2008
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 13 (2) , 123-135
Chromogranin B and Secretogranin II in Transgenic Mice Overexpressing Human APP751 with the London (V717I) and Swedish (K670M/N671L) Mutations and in Alzheimer Patients
Chromogranin B and secretogranin II are major soluble constituents of large dense core vesicles of presynaptic structures and have been found in neuritic plaques of Alzheimer patients. We examined the distribution and expression of these peptides in
- 18 March 2008
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 13 (2) , 123-135
Chromogranin B and Secretogranin II in Transgenic Mice Overexpressing Human APP751 with the London (V717I) and Swedish (K670M/N671L) Mutations and in Alzheimer Patients
Chromogranin B and secretogranin II are major soluble constituents of large dense core vesicles of presynaptic structures and have been found in neuritic plaques of Alzheimer patients. We examined the distribution and expression of these peptides in
- 1 January 2008
- Vol. 22 (1) , 1-15
[Sex differences in Alzheimer's disease].
The prevalence of Alzheimer disease is higher in women than in men. In the age group 65-69 years 0.7% of women and 0.6% of men suffer from the disease with increasing frequencies of 14.2% and 8.8% in individuals aged 85-89 years. The incidence is also higher in demented women. In Austria 74.1% of Alzheimer patients older than 60 years are women. Several studies report more pronounced language, mnestic, semantic and orientation deficits in women, but methodological shortcomings might be responsible for this finding. The validity of results reporting a more rapid cognitive decline in women can also be questioned. Women have a broader spectrum of dementiarelated behavioural symptoms with a predominance of depression, while aggression is more frequent in men than in women. Biological explanations for gender-specific differences in the phenotype of Alzheimer s disease include different brain morphology and function with higher susceptibility for pathological lesions in women and greater cognitive reserve in men. Sex differences were also reported for expression of antioxidative enzymes and post-menopausal hormonal changes. Interactions between gender nd response to treatment, if any, are subtle and have large intra-individual variability. In Austria, two thirds of patients receiving attendance allowance are women. Care takes place in 80% by the families and is provided by women in 78%. The rate of female care-givers in partly institutionalized care units in 91% in nursing homes it is 84%.
- 1 January 2008
- Vol. 22 (1) , 1-15
[Sex differences in Alzheimer's disease].
The prevalence of Alzheimer disease is higher in women than in men. In the age group 65-69 years 0.7% of women and 0.6% of men suffer from the disease with increasing frequencies of 14.2% and 8.8% in individuals aged 85-89 years. The incidence is also higher in demented women. In Austria 74.1% of Alzheimer patients older than 60 years are women. Several studies report more pronounced language, mnestic, semantic and orientation deficits in women, but methodological shortcomings might be responsible for this finding. The validity of results reporting a more rapid cognitive decline in women can also be questioned. Women have a broader spectrum of dementiarelated behavioural symptoms with a predominance of depression, while aggression is more frequent in men than in women. Biological explanations for gender-specific differences in the phenotype of Alzheimer s disease include different brain morphology and function with higher susceptibility for pathological lesions in women and greater cognitive reserve in men. Sex differences were also reported for expression of antioxidative enzymes and post-menopausal hormonal changes. Interactions between gender nd response to treatment, if any, are subtle and have large intra-individual variability. In Austria, two thirds of patients receiving attendance allowance are women. Care takes place in 80% by the families and is provided by women in 78%. The rate of female care-givers in partly institutionalized care units in 91% in nursing homes it is 84%.